FDA Approves PARSOL Shield, First New Sunscreen Active in U.S. in Over 25 Years

The U.S. Food and Drug Administration (FDA) has approved PARSOL Shield (bemotrizinol, BEMT) for the U.S. market, marking the first new sunscreen active ingredient approved in the country in over 25 years. Announced by dsm-firmenich, this approval is a significant milestone for sunscreen innovation and public skin health, expanding access to next-generation UV protection. Clinical studies demonstrated exceptional UV efficacy, excellent tolerability, and a strong safety profile.